Filing Details

Accession Number:
0001127602-24-014765
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-09 15:38:13
Reporting Period:
2024-05-07
Accepted Time:
2024-05-09 15:38:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
105770 West Pharmaceutical Services Inc WST Surgical & Medical Instruments & Apparatus (3841) 231210010
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1336007 Mark Eric Green 530 Herman O. West Drive
Exton PA 19341
President, Ceo And Board Chair Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-07 9,316 $57.38 162,224 No 4 M Direct
Common Stock Acquisiton 2024-05-07 15,684 $57.38 177,908 No 4 M Direct
Common Stock Acquisiton 2024-05-07 41,000 $59.64 218,908 No 4 M Direct
Common Stock Disposition 2024-05-07 9,316 $366.64 209,952 No 4 S Direct
Common Stock Disposition 2024-05-07 15,684 $366.66 193,908 No 4 S Direct
Common Stock Disposition 2024-05-07 41,000 $366.65 152,908 No 4 S Direct
Common Stock Acquisiton 2024-05-07 9,000 $59.64 161,908 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-05-07 9,316 $0.00 9,316 $57.38
Common Stock Stock Option (Right to Buy) Disposition 2024-05-07 15,684 $0.00 15,684 $57.38
Common Stock Stock Option (Right to Buy) Disposition 2024-05-07 41,000 $0.00 41,000 $59.64
Common Stock Stock Option (Right to Buy) Disposition 2024-05-07 9,000 $0.00 9,000 $59.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-04-24 2025-04-24 No 4 M Direct
0 2016-02-23 2025-04-24 No 4 M Direct
45,732 2017-02-23 2026-02-23 No 4 M Direct
36,732 2017-02-23 2026-02-23 No 4 M Direct
Footnotes
  1. The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in either 2025 or 2026, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 11/17/2023.
  2. The price reported in Column 4 is a weighted average price.